Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersGynecologic Oncology Physician in Columbia, MO
NPI: 1558441725Primary Practice Location
UNIVERSITY OF MISSOURI HEALTH CARE
1 Hospital Dr, Columbia, MO
Primary Employer
University Physicians Specialty Care Associates
muhealth.org
HQ Phone
Get M.D. Mark's Phone Numberphone_androidMobile
Get M.D. Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
MO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 76830Ultrasound pelvis through vagina | 57 | 60 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 37 | 46 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 29 | 76 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 29 | 33 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 25 | 25 |
A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Authors: Carolyn Mccourt, Kimberly Leslie, Jacob Rotmensch, Christopher Darus, Heidi Gray, Jeanne Schilder, David Bender
Publication Date: 2015-04-23
ARG1 is a potential prognostic marker in metastatic and recurrent endometrial cancer.
Authors: Tran, Dinh Nam, Rozen, Valery, Hunter, Mark I, Kim, Tae Hoon, Jeong, Jae-Wook
Journal: Res Sq
Publication Date: 2023-07-18
Authors: Niravkumar Brahmbhatt, Nancy Vander Velde, Cherian Verghese
Journal: J Hematol
Publication Date: 2024-12-02
Lead Sponsor: GOG Foundation
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, RADIATION: External Beam Radiation Therapy, DRUG: Cisplatin, OTHER: Quality-of-Life Assessment, RADIATION: Intensity-Modulated Radiation Therapy
